Avicanna Announces Closing of Non-Brokered Private Placement (opens original article in a new tab)

Avicanna completed a private placement raising $600,002.1 to support its operations and development.

• Avicanna closed a non-brokered private placement offering of 4,000,014 units at $0.15 per unit, raising $600,002.1.
• The proceeds will be used for general working capital, administrative expenses, production, and research and clinical development.
• Each unit includes one common share and half a warrant to purchase an additional share at $0.20 per share until June 2029.